Search results: Sage Journals

Open accessCase reportFirst published 2025

Probable lecanemab-associated pontine hemorrhage following cardiovascular intervention: Clinical implications for lecanemab use

Siwei Chen, Yongan Sun, Lanqiu Yao [...]

Journal of Alzheimer's Disease Reports

Restricted accessReview articleFirst published October, 2024

Lecanemab: A Humanized Monoclonal Antibody for the Treatment of Early Alzheimer Disease

Juliane Park, Carson Simpson, Katie Patel

Annals of Pharmacotherapy

Restricted accessArticle commentaryFirst published July 18, 2023

The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes

Kasper P. Kepp, Stefano L. Sensi, Kasper B. Johnsen [...]

Journal of Alzheimer’s Disease

Restricted accessResearch articleFirst published February, 2026

Real-world experience with baseline characteristics and safety of lecanemab for Alzheimer's disease in Eastern China

Lumin Leng, Zhengluan Liao, Peilin Lu [...]

Journal of Alzheimer’s Disease

Restricted accessReview articleFirst published June, 2025

Exploring the efficacy and safety of lecanemab in the management of early Alzheimer’s disease: A systematic review of clinical evidence

Rehab Emad Ashmawy, Olalekan John Okesanya, Bonaventure Michael Ukoaka [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published 2025

Sentiment analysis of social media responses to the approval of lecanemab for the treatment of Alzheimer's disease in Japan

Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara [...]

Journal of Alzheimer's Disease Reports

Open accessResearch articleFirst published July, 2026

The social value of lecanemab for patients with early Alzheimer's disease in Japan

Ataru Igarashi, Mie Azuma-Kasai, Mayaka Tani [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published October, 2023

Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer’s disease: A systematic review

Selia Chowdhury, Nurjahan Shipa Chowdhury

International Journal of Immunopathology and Pharmacology

Open accessCase reportFirst published 2025

Combined 64-channel EEG and PET evaluation of lecanemab efficacy: Two case reports

Xichun Wang, Yumei Liu, Shuhan Fan [...]

Journal of Alzheimer's Disease Reports

Open accessResearch articleFirst published 2024

Are There Shortages and Regional Disparities in Lecanemab Treatment Facilities? A Cross-Sectional Study

Kazuki Ohashi, Ikuko Takahashi-Iwata, Zhao Jieyu [...]

Health Services Insights

Open accessCase reportFirst published 2025

Probable lecanemab-associated pontine hemorrhage following cardiovascular intervention: Clinical implications for lecanemab use

Siwei Chen, Yongan Sun, Lanqiu Yao [...]

Journal of Alzheimer's Disease Reports

Restricted accessReview articleFirst published October, 2024

Lecanemab: A Humanized Monoclonal Antibody for the Treatment of Early Alzheimer Disease

Juliane Park, Carson Simpson, Katie Patel

Annals of Pharmacotherapy

Restricted accessArticle commentaryFirst published July 18, 2023

The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes

Kasper P. Kepp, Stefano L. Sensi, Kasper B. Johnsen [...]

Journal of Alzheimer’s Disease

Restricted accessResearch articleFirst published February, 2026

Real-world experience with baseline characteristics and safety of lecanemab for Alzheimer's disease in Eastern China

Lumin Leng, Zhengluan Liao, Peilin Lu [...]

Journal of Alzheimer’s Disease

Restricted accessReview articleFirst published June, 2025

Exploring the efficacy and safety of lecanemab in the management of early Alzheimer’s disease: A systematic review of clinical evidence

Rehab Emad Ashmawy, Olalekan John Okesanya, Bonaventure Michael Ukoaka [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published 2025

Sentiment analysis of social media responses to the approval of lecanemab for the treatment of Alzheimer's disease in Japan

Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara [...]

Journal of Alzheimer's Disease Reports

Open accessResearch articleFirst published July, 2026

The social value of lecanemab for patients with early Alzheimer's disease in Japan

Ataru Igarashi, Mie Azuma-Kasai, Mayaka Tani [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published October, 2023

Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer’s disease: A systematic review

Selia Chowdhury, Nurjahan Shipa Chowdhury

International Journal of Immunopathology and Pharmacology

Open accessCase reportFirst published 2025

Combined 64-channel EEG and PET evaluation of lecanemab efficacy: Two case reports

Xichun Wang, Yumei Liu, Shuhan Fan [...]

Journal of Alzheimer's Disease Reports

Open accessResearch articleFirst published 2024

Are There Shortages and Regional Disparities in Lecanemab Treatment Facilities? A Cross-Sectional Study

Kazuki Ohashi, Ikuko Takahashi-Iwata, Zhao Jieyu [...]

Health Services Insights